Popular Articles

Association Between Blood Transfusions And Infection
A study of almost 25,000 coronary artery bypass graft (CABG) patients has shown that receiving blood from another person is associated with a two-fold increase in post-operative infection rates. The research, published in the open access journal BMC Medicine, also found considerable hospital variation in transfusion practices.
generic viagra online
One Doctor's View: Electronic Medical Records Work Well
Doctors increasingly use email and electronic medical records to improve health care. In an essay in the Los Angeles Times, Rahul Parikh writes about his own experience at a Kaiser Permanente facility in Northern California where they implemented an electronic medical record system in 2006: "...notes, orders and prescriptions are clear and contiguous. There"s no waiting for paperwork. And if a patient of mine shows up in another office across town (remember, Kaiser is an integrated system -- we all share the same computer network), a doctor whom I have never met can see what I"ve written, my patient"s list of problems and what I"ve done for the patient in the past before he or she even sets foot in the room to talk to the patient. Such record systems can alert us to possible medication errors or dangerous drug interactions. They can continuously be updated to identify best practices. And they talk to patients as well, allowing them to access past-visit information and immunization records and to make appointments and send e-mails to their doctor."
News of the day
Green Paper Funding Proposals "Disastrous" For People With Mental Health Problems
People with mental health problems could find themselves without adequate help and support under proposals set out in today"s green paper on adult social care, warns leading mental health charity Rethink.
Diagnostics

ACCP Position Paper On Genetic Tests Advertised Directly To The Consumer

Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers" response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, according to a position paper from the American College of Clinical Pharmacology (ACCP) to be published in the August 2009 issue of the Journal of Clinical Pharmacology. The journal is published on behalf of the ACCP by SAGE. According to the article, "Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology," prescription medications have been advertised in the US for 10+ years with a defined oversight of the process, however, there"s no comparable supervision for advertised genetic testing. In order for the consumer to have a positive experience with choosing genetic testing from advertising, clinical pharmacologists believe that effective governmental oversight is imperative, along with assistance from professional clinicians. Clinical pharmacologists should also help prepare consumers for possible risks of the tests and work closely with those who are considering taking further action in response to an advertisement of genetic testing, providing the following cautionary advice: * Verify with a professional, the information presented in advertisements of genetic testing * Seek advice from a genetic clinician, not just a general health care professional * Recognize the scientific limitations of each test, especially since the information isn"t necessarily translatable when it"s time to make therapeutic decisions. * Realize that many companies selling genetic testing services do not provide interpretation of results. Commenting on the expanding frontiers of health professions, the authors conclude, "Clinical pharmacology will have a voice in how the evolving science translates not only into clinical trials and patient care but also into regulations involving the promotion and advertising of all genetic tests. Clinical pharmacologists can help ensure that realistic expectations of genetic tests are communicated, thereby mitigating psychological, social, and medical risks." "Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology" by Barbara Ameer, PharmD, MBA, of the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, and Norberto Krivoy, MD, of the Center for Translational Genetics, B. Rappaport Institute for Research in Medical Sciences, and Clinical Pharmacology Institute, Rambam Health Care Campus and Technion - Israel Institute of Technology, is being made available free of charge for a limited time at http://jcp.sagepub.com/cgi/content/full/49/8/886. Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):